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Abstract Glutamate transport (GluT) in brain is mediated
chieﬂy by two transporters GLT and GLAST, both driven
by ionic gradients generated by (Na
?,K
?)-dependent
ATPase (Na
?/K
?-ATPase). GLAST is located in astro-
cytes and its function is regulated by translocations from
cytoplasm to plasma membrane in the presence of GluT
substrates. The phenomenon is blocked by a naturally
occurring toxin rottlerin. We have recently suggested that
rottlerin acts by inhibiting Na
?/K
?-ATPase. We now
report that Na
?/K
?-ATPase inhibitors digoxin and ouabain
also blocked the redistribution of GLAST in cultured
astrocytes, however, neither of the compounds caused
detectable inhibition of ATPase activity in cell-free
astrocyte homogenates (rottlerin inhibited app. 80% of
Pi production from ATP in the astrocyte homogenates,
IC50 = 25 lM). Therefore, while we may not have
established a direct link between GLAST regulation and
Na
?/K
?-ATPase activity we have shown that both ouabain
and digoxin can interfere with GluT transport and therefore
should be considered potentially neurotoxic.
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Introduction
GLutamate and ASpartate Transporter (GLAST) is one of
the two most important transporters handling acidic amino
acids in brain tissue (the other being GLT; for reviews see
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DOI 10.1007/s11064-010-0274-4[1–4]). Glutamate transport (GluT) is driven by free energy
generated in the form of ionic gradients by (Na
?,K
?)-
dependent ATPase (Na
?/K
?-ATPase). GLAST is located
in actrocytes and its function appears to be regulated by
rapid translocations between cytoplasm and the cell
(plasma) membrane in response to the presence of sub-
strates in the extracellular space [5–7]. The precise nature
of the mechanism underlying these shifts is not understood
but probably involves phosphorylation and changes in the
activity of Na
?/K
?-ATPase [7–10].
Na
?/K
?-ATPase is a membrane-located enzyme which
breaks down ATP and uses the resulting energy to maintain
Na
? and K
? gradients across the cell membranes. It is
found in virtually all cells and tissues but its activity and
normal functioning would seem to be critically important
in brain considering that the neuronal action potentials
involve large increases in membrane permeability to both
K
? and Na
? and, at the same time, the most important
excitatory neurotransmitter and potential neurotoxin
L-glutamate (for reviews see [11–13]) is cleared and inac-
tivated by uptake into astrocytes via GluT, i.e. by a process
driven by Na
?/K
?-ATPase-generated Na
? and K
? con-
centrations gradients [1, 2, 14]. Indeed, there may be not
only functional but, also, close structural relationship
between Na
?/K
?-ATPase and GluT [15–17].
Alterations in the activity of Na
?/K
?-ATPase have been
noted in brain diseases, particularly those associated with
elevated levels of extracellular glutamate. Rapport et al.
[18] reported 60% decrease in Na
?/K
?-ATPase in the
cerebral cortex of patients with epilepsy, global loss of
Na
?/K
?-ATPase was found in a transgenic mouse model
of amyotrophic lateral sclerosis [19] and the ionic move-
ments occurring as a result of ischemia and hypoglycemia
[20, 21] were consistent with a decrease in Na
?/K
?-
ATPase activity. Inadequate Na
?/K
?-ATPase activity
could, therefore, compromise normal function of GluT and
lead to increases in extracellular glutamate resulting in
neurotoxic events [3, 4, 22–24]. In fact, it has been known
for some time that the Na
?,K
?-ATPase inhibitor ouabain
is a powerful inhibitor of GluT in brain tissue [25, 26] and
can act as a neurotoxin in vivo [27–29].
Recently, we have suggested that the disruption of
GLAST trafﬁc between cytoplasm and cell membrane
caused by a protein kinase C-d (PKC- d) inhibitor and
metabolic poison rottlerin could be explained by inhibition
of Na
?/K
?-ATPase [10]. Such explanation raises a possi-
bility that other Na
?/K
?-ATPase inhibitors could have
similar effects on GLAST. In addition, inhibition of Na
?/
K
?-ATPase activity accompanied by the loss of rapid
regulation of GluT, effectively blocking an increase in
GLAST activity in response to increased extracellular
glutamate, could lead to pathologically high levels of
L-glutamate around sensitive neurons. Therefore, naturally
occurring Na
?/K
?-ATPase inhibitors (e.g. endogenous
cardiac glycosides) and, in some cases such as digoxin,
therapeutically used drugs, could be potentially highly
neurotoxic if they entered into and/or, were allowed to
build up to high concentrations in, the brain.
The chief aim of the present study has been to test whe-
ther ouabain and digoxin could alter the D-aspartate induced
redistribution of GLAST in glial cells. As an experimental
model we have used, as in previous similar studies, cultured
rat astrocytes in which GLAST transporter was immuno-
ﬂuorescently labelled by a custom made antibody [30] and
the subcellular location of the immunoﬂuorescence was
studied using deconvolution microscopy [9, 10].
Experimental Procedure
Cultured Astrocytes
Cultured astrocytes were prepared from brains of neonatal
Sprague–Dawley rats as described elsewhere [9]. Cells
were ﬁrst grown in Dulbecco modiﬁed Eagle’s medium
(DMEM) supplemented with 10% foetal bovine serum
(FBS) in 25 cm
2 ﬂasks, then passaged onto coverslips
(13 mm in diameter) and maintained until they reached
even distribution.
Immunocytochemistry
The methodology was described in recent publications
[9, 10]. The coverslips with astrocytes were washed and
incubated in the presence of D-aspartate and/or drugs dis-
solved in 500 ll of serum-free DMEM (sfDMEM). Incu-
bations (30 min) were carried out at 37Ci n5 %C O 2.
Drug-free sfDMEM was used as a control.
Following the exposure to D-aspartate and/or rottlerin,
the astrocytes were double-labelled with antibodies against
glial ﬁbrillary acidic protein (GFAP, marker for astrocytes,
mouse monoclonal antibodies) and antibodies against the
glutamate transporter GLAST (polyclonal antibody raised
in rabbit; [30]). The antibodies were diluted in phosphate
buffered saline (PBS) containing 1% bovine serum albumin
(BSA) and 0.05% saponin. The coverslips were ﬁrst
washed in 2 ml of PBS for 5 min, then ﬁxed with para-
formaldehyde (2% in PBS) for 10 min and again washed
with 2 ml of PBS for 5 min. The preparation was then
‘‘blocked’’ with the BSA-containing PBS (BSA/PBS) for
30 min and exposed to 200 ll of solutions containing the
antibodies at dilutions of 1:4,000 (GLAST) and 1:400
(GFAP). The incubations (2 h) were carried out at room
temperature in a humidiﬁed environment. The coverslips
were then washed three times for 5 min with 2 ml of the
BSA/PBS solution and exposed to secondary antibodies.
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123Goat-generated anti-mouse IgG conjugated to Alexa
Fluor 488 (AF 488) was used to visualize GFAP while
goat-generated anti-rabbit IgG conjugated to Alexa Fluor
594 (AF 594) was used to label the anti-GLAST antibody.
Both secondary antibodies were diluted in the BSA/PBS
solution; incubations were for 1 h at room temperature and
washed as described above for the primary antibodies;
three times for 5 min with 2 ml of BSA/PBS.
After washing, the coverslips were blotted and mounted
upside down, using 50% solution of glycerol in PBS, on
slides and secured along the edges with nail polish.
Deconvolution Microscopy and Image Analysis
Deconvolution microscope (Axioplan 2, Zeiss) was used
for image acquisition [9, 10]. AF 488 and AF 594 were
excited at 499 nm (emission at 520 nm) and 590 (emission
at 618 nm) respectively. The images were optically
sectioned at 0.513 lm intervals and subjected to decon-
volution using an inverse ﬁlter algorithm to remove out-of-
focus (background) signals. Sections from the midplane of
the stacks (usually ﬁve to seven sections) were used for the
image analyses. Examples of such sections are shown in
Fig. 1. Each image represented a randomly selected single
cell.
Mean ﬂuorescence density (MFD) was determined in
both the cytoplasm and membrane (cMFD and mMFD) and
the membrane/cytoplasm ratio of ﬂuorescent intensity
(RFI = mMFD/cMFD) was used as an index of the dis-
tribution of GLAST between membrane and cytoplasm.
Examples of such distributions in ﬂuorescence density are
shown in Fig. 2.
Activity of Na
?,K
?-Dependent ATPase in Prisms
of Adult Cerebral Cortex
We have used a technique that employs uptake of Rb
? as a
measure of the activity of (Na
?,K
?)-dependent ATPase in
rat brain tissue. The methodology is similar to that used to
study uptake of radiolabelled amino acid [25] and has
been described in detail earlier [26]. Prisms of adult
(3–6 months) rat cerebral cortex (0.1 9 0.1 9 thickness of
cortex) were suspended at 25 mg/10 ml of incubation
medium (phosphate buffered Krebs–Ringer; [31]) and
allowed 15 min for recovery in a shaking water bath at
37C. Uptake of Rb
? was started by adding 500 ll of the
medium in which 5 mM KCl was replaced by 5 mM RbCl.
Incubation was terminated 10 min later by rapid ﬁltration
(assisted by negative-pressure at *20 psi) through What-
man No. 1 ﬁlters (2.5 cm in diameter) and washing the
Fig. 1 Distribution of GLAST
immunoreactivity (IR) in
cultured astrocytes. Green
ﬂuorescence marks glial
ﬁbrillary acidic protein, red
corresponds to GLAST IR. Top
two panels are controls (a and
b); absence of added glutamate
transport substrates, bottom two
panels (c and d) are cells in the
presence of 500 lM D-aspartate.
The left two panels (a and
c) show combination of GLAST
and GFAP IR, the panels on the
right (b and d) show GLAST IR
only. Scale bar = 10 lm. For
interpretation of the references
to color in this ﬁgure legend, the
reader is referred to the online
version of this article
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123ﬁlters twice with 2 ml of RbCl-free medium. The ﬁlters
were then extracted overnight with 1.5 ml of deionized
water and the concentration of Rb
? in the extracts esti-
mated using acetylene-ﬂame atomic absorption spectros-
copy (AAS).
ATPase Activity Studied by Production of Pi (Inorganic
Phosphate)
Conﬂuent rat cultured astrocytes were mechanically
detached from the cultured ﬂasks and homogenized in ice-
cold homogenization medium (containing 250 mM
sucrose, 5 mM EDTA, 20 mM imidazole, pH 7.4) at 3%
(w/v) using a glass-glass homogenizer and frozen at app.
-20C. The homogenates were later thawed and ﬁrst
preincubated (aliquots of 150 ll) for 10 min at 37C in the
assay medium (containing 30 mM histidine, 4 mM MgCl2,
128 mM NaCl and 20 mM KCl, pH 7. 4) with or without
the drugs.
Estimation of ATPase activity followed an established
method [32]: Following the preincubation, 3 mM ATP was
added to the samples to initiate the activity of ATPase(s)
and the incubation was continued for 10 min. The reaction
was terminated by the addition of an equal volume of ice-
cold 0.8 N perchloric acid. The samples were centrifuged
at 1,200g at 2C for 15 min in a Hettich Universal 16R
centrifuge. Aliquots of 250 ll from the centrifuged solu-
tion were transferred into cuvettes and diluted with 250 ll
of distilled water. A volume (500 ll) of the colour reagent
was then added. The colour reagent was prepared by dis-
solving 4 g of FeSO47H2O in 100 ml of a 1% ammonium
molybdate ((NH4)6Mo7O244H2O) solution in 3.3 ml of
98% H2SO4, and was used within 2 h after the preparation,
was added to the cuvettes. The absorbance of the cuvettes
was read after 10 min of the resulting colour at 750 nm by
a UV-1601 UV–Visible spectrophotometer Shimadzu,
Tokyo, Japan. The standard used for inorganic phosphate
was from a stock solution of 1 mM KH2PO4.
Fig. 2 Example of GLAST IR density distribution across cells
displayed as XY plots and histograms. The ﬂuorescence intensity
(optical density of the ﬂuorescence produced by AF 594, see
Experimental Procedure for details) is in units provided by the
deconvolution microscope, the distance units are arbitrary. The top
two panels are controls, bottom two panels show the distribution in
the presence of 500 lM D-aspartate. The panels on the left show
examples of lines across osingle cells while those on the right show
mean ﬂuorescence density inside cells (‘‘In’’, i.e. in the cytoplasm,
cMFD) or at the perimeter, close to, or at, the plasma membrane
(‘‘Out’’, mMFD), determined as described in detail in [9, 10]. RFI is
the ratio of mMFD to cMFD [9] and, when calculated from the data
shown in the panels on the right (means ± SEM from ﬁve controls,
six in the presence of D-aspartate), it was found to be signiﬁcantly
higher (at P\0.001 by unpaired t-test) in the presence of D-aspartate
when compared to controls
Neurochem Res (2010) 35:2062–2069 2065
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The data were analysed by using the Prism Software
(GraphPad, San Diego Ca, USA). Lines were ﬁtted by
linear regression. Values are shown as mean ± SEM.
Statistical comparisons were evaluated by using one way
analysis of variance (ANOVA), Tukey’s multiple com-
parison test or unpaired t-test.
Chemicals
Antibodies against GFAP were obtained from SIGMA
Chemical Company (St. Louis, Mo, USA), the AF sec-
ondary antibodies were purchased from Bioscientiﬁc Pty
Ltd. (Sydney, Australia).
Rottlerin was purchased from Calbiochem (La Jolla,
CA, USA), ouabain, digoxin, ATP (adenosine triphos-
phate), EDTA (ethylenediaminotetraacetic acid), DMSO
(dimethyl sulfoxide), imidazole and all tissue culture sup-
plies were from Sigma Chemical Co (St. Louis, MO.,
USA). D-Aspartate was a gift from Prof. Graham Johnston
(Department of Pharmacology, The University of Sydney).
All other chemicals were of analytical grade and were
purchased from commercial suppliers. Rottlerin was solu-
bilized using DMSO [10] while digoxin was solubilized by
ethanol (ﬁnal contribution from ethanol was 0.7% and this
concentration was either included in the control or it was
established in separate experiments that it had no effect on
the reaction studied).
Results
Effects of Na
?/K
?-ATPase Inhibitors
on the Distribution of GLAST in Astrocytes
In the absence of drugs the ﬂuorescence-labelled GLAST
immunoreactivity (GLAST-IR) was distributed approxi-
mately equally between cytoplasm and the areas at, or in
the immediate vicinity of, the plasma membrane. Even
though the distribution of GLAST-IR within the cytoplasm
was not even, the values of RFI (ratio of mean ﬂuorescence
density in cytoplasm to mean ﬂuorescence density at or
near the plasma membrane, mMFD/cMFD) were close to
one (Fig. 3). In the presence of D-aspartate RFI increased
and reached values of about 1.5–1.8 (signiﬁcantly different
from controls at P\0.001; Figs. 2 and 3). Neither digoxin
nor ouabain (at 100 lM) alone had any effect on the
GLAST-IR distribution, however, both Na
?/K
?-ATPase
inhibitors prevented the D-aspartate induced translocation
of GLAST-IR towards the plasma membranes (signiﬁ-
cantly different from D-aspartate exposed cells at P\0.01,
not different from controls at P[0.05; Fig. 3).
Studies of Na
?/K
?-ATPase Activity in Cortical Prisms
and Astrocyte Homogenates
Neither 1 mM ouabain nor 100 lM digoxin caused
signiﬁcant inhibitions of Pi production from ATP by
homogenates of astrocyte membranes. This could have
been caused not only by low activities of ouabain- and
digoxin-sensitive Na
?/K
?-ATPase in the homogenates but
also by low signal-to-noise ratios resulting from small
amounts of tissue (limited by the availability of cultured
astrocytes). The mean values of controls varied from
experiment to experiment between about 16 and 26 lg
Pi/mg protein/hour. Rottlerin, however, produced, under
similar experimental conditions, statistically signiﬁcant
inhibitions of Pi production, with maximum inhibition
(Imax) computed at about 80% (Fig. 4). Additionally, we
tested digoxin against Rb
? uptake by prisms of rat cerebral
cortex to estimate its activity as an inhibitor of Na
?/K
?-
ATPase in adult brain tissue. We obtained a signiﬁcant
dose-dependent effect (Fig. 5). Uptake of Rb
? by tissue
prisms prepared from adult rat cerebral cortex has been
used as a quantitative measure of Na
?/K
?-ATPase activity
previously [10, 26].
Discussion
As in previous studies [9, 10], the present experiments
using immunocytochemistry have indicated that, in
Fig. 3 Relative ﬂuorescence intensity (RFI, see legend of Fig. 2 and
[9]) for GLAST IR in the presence of D-aspartate and the cardiac
glycosides ouabain and digoxin (both at 100 lM; values are mean ±
S.E.M. obtained from the number of cells shown in parenthesis).
**Statistically different from the values obtained in the presence of
D-aspartate at P\0.01 by ANOVA, using Tukey’s multiple
comparison test
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123cultured astrocytes, the glutamate transporter GLAST
translocates from cytoplasm to plasma membrane in
response to the presence of D-aspartate. The most parsi-
monious interpretation of earlier data [6, 7, 33] would be
that the presence of GluT substrates in the vicinity of
GLAST-expressing astrocytes triggers a process resulting
in translocation of additional GLAST molecules to the
plasma membrane. Accordingly, greater availability of
substrate(s) would cause higher activity of GluT and this
would lead to the recruitment of additional transporter
(GLAST) molecules at the surface of the cell. Therefore,
the most straightforward explanation of our main ﬁndings
would be that D-aspartate did not induce the GLAST
translocation when ouabain and digoxin were present
because GluT activity could not increase while Na
?/K
?-
ATPase was inhibited.
However, the inhibition of GLAST trafﬁc by ouabain
and digoxin may not be simply caused by an overall
decrease in free energy supply resulting from a nonselec-
tive inhibition of Na
?/K
?-ATPase. This is underscored by
the lack of an observable effect of digoxin and ouabain on
the Pi production by ATPase activity in the cell-free
preparations (though some degree of Na
?/K
?-ATPase
inhibition by ouabain in intact cell cultures has been
observed; [10]). More likely, ouabain and digoxin would
have a strong effect on only a small portion of the total
Na
?/K
?-ATPase activity, perhaps mediated by an isoform
of the enzyme which is speciﬁcally susceptible to the
inhibition by ouabain and digoxin. Inhibition of this frac-
tion of the enzyme would then be enough to stop the
translocation and activation of GLAST.
In a previous study, ouabain, when tested in rat cerebral
cortical tissue in vitro, produced strong inhibition of GluT
(IC50\1 lM) but was at least an order of magnitude
weaker (IC50 app. 17 lM) as an inhibitor of Na
?/K
?-
ATPase activity [23]. In other words, almost all GluT in
those experiments was inhibited at ouabain concentrations
which had only marginal effect on the overall activity of
Na
?/K
?-ATPase in the tissue [26]. Such ﬁndings, too,
could be explained by postulating a link between a highly
ouabain-sensitive form of Na
?/K
?-ATPase (which would
account for only a small fraction of the total Na
?/K
?-
ATPase and glutamate transport, in agreement with con-
clusions based on other studies [34]. It has also been
pointed out that administration of ouabain into neonatal rat
brains in vivo can produce excitotoxic events, putatively
caused by increased extracellular levels of L-glutamate,
even when no major disruption of energy metabolism could
be detected [29]. That observation, too, is consistent with
the notion that only a small but strategically positioned
fraction of Na
?/K
?-ATPase is of crucial importance for the
normal function of GluT.
Regardless of whether ouabain and digoxin act primarily
by disrupting of a close functional link between GluT
(GLAST) and a subset of Na
?/K
?-ATPase molecules or by
directly interfering with the GLAST translocation to the
plasma membrane, both compounds should be viewed as
potentially serious neurotoxins.
In summary, the present study has demonstrated that
(Na
?,K
?)-dependentATPaseinhibitorsouabainanddigoxin
can inhibit the cytoplasm-to-membrane translocation of
Fig. 4 Inhibition of ATPase (Pi production from ATP) in astrocyte
homogenates by rottlerin. Values relative to control (100) are plotted
against Log of rottlerin concentration (lM). For details how the
lines and constants (mean ± S.E.M.) were computed see [35]. ‘‘n’’
corresponds to the number of points (as circles in the ﬁgure)
Fig. 5 The effect of digoxin on Rb
? by rat cortex prisms. Details as
described in legend of Fig. 4, methodology is discussed in Ref. [26]
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123glutamate transporter GLAST. The mechanism does not
appear to depend on an overall inhibition of (Na
?,K
?)-
dependent ATPase activity but an involvement of a small
fraction of (Na
?,K
?)-dependent ATPase linked directly to
GluT cannot be ruled out. The ﬁndings have implications for
the mechanisms underlying neurotoxicity of ouabain and
digoxin.
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